TABLE OF CONTENTS
|
 |  |  |
Volume 93, Issue 3 (March 2013) |
 | In this issue In This Issue Editorial News & Views Perspectives Development Discovery Regulation & Use State of the Art Reviews Research
Also new    AOP
| |
 |
 |
 |
| Advertisement |
 |
Meet the Editors of Clinical Pharmacology & Therapeutics and CPT: Pharmacometrics & Systems Pharmacology Join us at the ASCPT Annual Meeting March 8, 2013. View complete details here. | |
 |
| |
In This Issue | Top |
 |
In This IssueClin Pharmacol Ther 2013 93: 213; 10.1038/clpt.2012.267 Full Text |
 |
Editorial | Top |
 |
Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase InhibitorsC D Drenberg, S D Baker and A Sparreboom Clin Pharmacol Ther 2013 93: 215-219; 10.1038/clpt.2012.247 Abstract | Full Text |
 |
News & Views | Top |
 |
HIGHLIGHTS |
Clin Pharmacol Ther 2013 93: 220-221; 10.1038/clpt.2012.266 Full Text |
 |
 |
 |
ASCPT NEWS |
Clin Pharmacol Ther 2013 93: 222-227; 10.1038/clpt.2012.248 Full Text |
 |
 |
 |
MACROSCOPY |
Without Therapeutic Drug Monitoring, There Is No Personalized Cancer CareJ H Beumer Clin Pharmacol Ther 2013 93: 228-230; 10.1038/clpt.2012.243 Full Text |
 |
Perspectives | Top |
 |
COMMENTARY |
The State of Clinical Pharmacology TodayJ Gray Clin Pharmacol Ther 2013 93: 231-232; 10.1038/clpt.2012.231 Abstract | Full Text |
 |
 |
 |
LETTERS TO THE EDITOR |
Doubt About the Feasibility of Preemptive GenotypingB C P Koch, R H N van Schaik, T van Gelder and R H J Mathijssen on behalf of the Rotterdam Clinical Pharmacology-Pharmacogenetics Group (RCPPG) Clin Pharmacol Ther 2013 93: 233; advance online publication, December 12, 2012; 10.1038/clpt.2012.191 Full Text |
 |
 |
 |
Response to “Doubt About the Feasibility of Preemptive Genotyping”J C Denny, J S Schildcrout, J M Pulley and D M Roden Clin Pharmacol Ther 2013 93: 234; advance online publication, November 7, 2012; 10.1038/clpt.2012.223 Full Text |
 |
 |
 |
SSRIs: A Premature BurialK Jensen Clin Pharmacol Ther 2013 93: 234-235; advance online publication, December 19, 2012; 10.1038/clpt.2012.190 Full Text |
 |
 |
 |
Response to “SSRIs: A Premature Burial”P Weeke and C Torp-Pedersen Clin Pharmacol Ther 2013 93: 235; advance online publication, December 3, 2012; 10.1038/clpt.2012.232 Full Text |
 |
Development | Top |
 |
Physiologically Based Pharmacokinetic Models of Tyrosine Kinase Inhibitors: A Systems Pharmacological Approach to Drug DispositionJ M Gallo Clin Pharmacol Ther 2013 93: 236-238; advance online publication, December 18, 2012; 10.1038/clpt.2012.244 Full Text |
 |
Discovery | Top |
 |
Imaging of TKI–Target Interactions for Personalized Cancer TherapyA J Poot, P Slobbe, N H Hendrikse, A D Windhorst and GAMS van Dongen Clin Pharmacol Ther 2013 93: 239-241; advance online publication, December 12, 2012; 10.1038/clpt.2012.242 Full Text |
 |
Regulation & Use | Top |
 |
PRACTICE |
Playing Russian Roulette With Tyrosine Kinase InhibitorsR Z Szmulewitz and M J Ratain Clin Pharmacol Ther 2013 93: 242-244; advance online publication, December 18, 2012; 10.1038/clpt.2012.245 Full Text |
 |
State of the Art | Top |
 |
Drug Shortages: The Cycle of Quantity and QualityS L Kweder and S Dill Clin Pharmacol Ther 2013 93: 245-251; advance online publication, December 6, 2012; 10.1038/clpt.2012.235 Abstract | Full Text |
 |
Reviews | Top |
 |
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance OpenD Gonzalez de Castro, P A Clarke, B Al-Lazikani and P Workman Clin Pharmacol Ther 2013 93: 252-259; advance online publication, December 7, 2012; 10.1038/clpt.2012.237 Abstract | Full Text |
 |
 |
 |
Gender Differences in Drug Bioequivalence: Time to Rethink PracticesG Koren, H Nordeng and S MacLeod Clin Pharmacol Ther 2013 93: 260-262; advance online publication, December 3, 2012; 10.1038/clpt.2012.233 Abstract | Full Text |
 |
 |
 |
Intracellular Drug ConcentrationsC T Dollery Clin Pharmacol Ther 2013 93: 263-266; advance online publication, December 11, 2012; 10.1038/clpt.2012.240 Abstract | Full Text |
 |
Research | Top |
 |
ARTICLES |
Multiple Dosing of Ephedra-Free Dietary Supplements: Hemodynamic, Electrocardiographic, and Bacterial Contamination EffectsL Foster, M C Allan, A Khan, P Moore, D K Williams, M Hubbard, L Dixon and B J Gurley Clin Pharmacol Ther 2013 93: 267-274; advance online publication, December 11, 2012; 10.1038/clpt.2012.241 Abstract | Full Text |
 |
 |
 |
Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese SubjectsM Ulvestad, I B Skottheim, G S Jakobsen, S Bremer, E Molden, A Åsberg, J Hjelmesæth, T B Andersson, R Sandbu and H Christensen Clin Pharmacol Ther 2013 93: 275-282; advance online publication, December 27, 2012; 10.1038/clpt.2012.261 Abstract | Full Text |
 |
 |
 |
 |
Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
 |
| |
No comments:
Post a Comment